Expert says H.R. 3 won't inhibit pharmaceutical innovation in So-Cal | State of Reform

Retrieved on: 2021-08-18 23:37:30

Tags for this article:

Health sciences

Healthcare reform in the United States

Health

Pharmacy

Drug pricing

Pharmaceutical industry

Pharmaceuticals policy

Medicare

Elijah Cummings Lower Drug Costs Now Act

Medication costs

West Health

Medicare Prescription Drug, Improvement, and Modernization Act

Click the tags to see associated articles and topics

Expert says H.R. 3 won't inhibit pharmaceutical innovation in So-Cal | State of Reform. View article details on HISWAI: https://stateofreform.com/featured/2021/08/expert-says-hr-3-wont-inhibit-pharmaceutical-innovation-in-so-cal-contradicting-claims-from-phrma/

Excerpt

A study from West Health and Gallup showed a majority of Americans support allowing Medicare to negotiate these prices to lower costs for patients.

Article found on: stateofreform.com

View Original Article